Natera

Partner Manager (UK)

England, United Kingdom

Not SpecifiedCompensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
AI & Machine Learning, Consumer Software, FintechIndustries

Requirements

Candidates should have a proven track record in account management or business development, preferably within the technology or SaaS industry. Experience working with high-profile organizations and familiarity with the FTSE 100 and Fortune 500 is essential, along with strong relationship-building skills and the ability to engage with C-level executives. A background in AI solutions or video technology is a plus.

Responsibilities

The Partner Manager will work closely with the CEO, Chief of Staff, and Operations Director to drive revenue growth by identifying and nurturing relationships with key strategic partners. They will manage a portfolio of large consulting firms and enterprises, develop joint go-to-market strategies, and create co-selling opportunities. This role will involve engaging with high-level executives to achieve ambitious revenue targets.

Skills

Account Management
Sales
Business Development
SaaS
Relationship Building
Executive Communication
Revenue Growth

Natera

Genetic testing and diagnostics solutions provider

About Natera

Natera focuses on genetic testing and diagnostics, providing advanced solutions for cancer patients, transplant patients, and individuals assessing hereditary health risks. Their main technology is cell-free DNA (cfDNA) testing, which analyzes DNA fragments in the blood to detect minimal traces of cancer and assess organ health. Natera stands out by offering specialized tests like the Signatera ctDNA test and Panorama NIPT, along with genetic counseling services. The company's goal is to improve patient care and health outcomes through accurate genetic testing.

Key Metrics

Austin, TexasHeadquarters
2004Year Founded
$149.9MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
1,001-5,000Employees

Benefits

Flexible medical plans
Investment options
Time off
Workplace perks

Risks

Hindenburg report accuses Natera of deceptive sales practices, risking legal challenges.
New Prospera Heart features may face slow adoption by healthcare providers.
Fetal RhD NIPT demand may drop post-RhIg shortage, affecting future sales.

Differentiation

Natera's Signatera test offers personalized ctDNA analysis for cancer patients.
Prospera Heart test uses unique Donor Quantity Score for transplant rejection detection.
Panorama NIPT test is a leader in non-invasive prenatal testing with 2 million tests.

Upsides

Increased adoption of liquid biopsy techniques boosts demand for Natera's cfDNA tests.
AI integration enhances accuracy and speed of Natera's cfDNA analysis.
Growing personalized medicine trend aligns with Natera's customized genetic tests.

Land your dream remote job 3x faster with AI